[Causes of primary amenorrhea in children].

P. Grigorescu Sido,D. Olinici,C. Colesnicov,E. Opincaru,S. Imreh

1984-10-01

Abstract:

What problem does this paper attempt to address?

Simplified quantification of insulin, its synthetic analogs and C-peptide in human plasma by means of LC-HRMS

Andreas Thomas,Rouxue Yang,Simon Petring,Lia Bally,Mario Thevis

DOI: https://doi.org/10.1002/dta.2765

Abstract:The quantification of peptide hormones by means of liquid chromatography (LC) coupled to mass spectrometry (MS) or other techniques (e.g. immunoassays) has been a challenging task in modern analytical chemistry. Especially for insulin, its synthetic analogs, and C-peptide, reliable determinations are urgently needed due to their diagnostic value in the management of diabetes and insulin resistance and because of the illicit use of insulin as a performance-enhancing agent in professional sports or as an effective toxin in forensic toxicology. The concomitant measurement of C-peptide and insulin offers an established tool for the diagnostic workup of hypoglycemia (endogenous vs. exogenous hyperinsulinemia), characterizing hepatic insulin clearance, and the assessment of beta-cell function (insulin secretion). Thus, the present approach offers the possibility to determine human insulin and its synthetic analogs (lispro, glulisine, aspart, glargine metabolite, degludec, detemir, porcine, and bovine) and C-peptide simultaneously after sample preparation utilizing protein precipitation and a mixed-mode cation-exchange solid-phase extraction, and subsequent detection by LC-high resolution MS. The method was fully validated regarding the following parameters: specificity, limit of detection (0.2 ng/mL), limit of quantification (0.6 ng/mL), recovery (40-90%), accuracy (78-128%), linearity, precision (< 21%), carry over, robustness, and matrix effects. The proof-of-concept was shown by analyzing authentic plasma samples from adults with class II obesity and prediabetes collected in the course of an oral glucose tolerance test. All sample preparation steps were controlled by two stable isotope-labeled internal standards, namely [[2 H10 ] Leu B6, B11, B15, B17 ]-insulin, and [[13 C6 ] Leu 26, 30 ] C-peptide.
Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry

Andreas Thomas,Mario Thevis

DOI: https://doi.org/10.1002/dta.2518

Abstract:While dried blood spot (DBS) analysis concerning low molecular mass molecules has become more and more established in various fields of analytical chemistry, the utility of DBS in determining peptides and proteins from DBS is yet comparably limited. In consideration of the fact that the apparent benefits of DBS sampling are similar for analytes of lower and higher molecular mass, dedicated (non-generic) sample preparation procedures are required that meet the needs for detecting peptidic drugs and hormones in DBS. The analysis of insulin and its synthetic analogs by mass spectrometry has received increased attention in several fields such as doping controls, forensics, and drug metabolism and pharmacokinetics studies. Hence, a strategy facilitating the analysis of insulin and its synthetic or animal analogs (human, Lispro, Aspart, Glulisine, Glargine, Detemir, Tresiba, and porcine and bovine insulin) from DBS was developed. The successful analysis of these substances at physiologically relevant concentrations was realized after ultrasonication-assisted extraction, immunoaffinity purification, and liquid chromatographic separation followed by high resolution mass spectrometric detection (with or without ion mobility). Assay validation demonstrated adequate sensitivity (LOD 0.5 ng/mL for most insulins), as well as precise (< 25%) and reproducible results for all included target insulins. Additionally, proof-of-principle data were obtained by the analysis of DBS samples obtained from healthy volunteers in non-fasting state as well as a sample from a diabetic volunteer treated with the fast acting analog insulin Aspart.
Quantification of Insulin Analogs by Liquid Chromatography-High-Resolution Mass Spectrometry

Erica M Fatica,Nicholas E Larkey,Ravinder J Singh

DOI: https://doi.org/10.1007/978-1-0716-2565-1_20

Abstract:Administration of exogenous insulin or insulin analogs is a common cause of hypoglycemia. The etiology of hypoglycemic episodes can be investigated by the measurement of insulin. However, frequently used synthetic insulin analogs show variable reactivity with immunoassays designed for the quantification of human insulin and may produce misleading results. To overcome this challenge, mass spectrometric methods can be applied to differentiate and accurately quantify insulin and its analogs. Here we describe a liquid chromatography-tandem high-resolution accurate mass (LC-HRAM) for the highly specific and independent quantification of insulin and its synthetic analogs including aspart, detemir, glargine, glulisine, and lispro. This method utilizes antibody affinity extraction followed by analysis on a high-resolution accurate mass spectrometer.
Hb Setif [alpha 94(G1)Asp-->Tyr] in Malta.

I. Borg,M. Valentino,A. Fiorini,A. Felice

DOI: https://doi.org/10.3109/03630269708997513

Hemoglobin

Abstract:
A Dual Functional-Group Derivatization Liquid Chromatography–Tandem Mass Spectrometry Method: Application for Quantification of Human Insulin

Yohei Sakaguchi,Tomoya Kinumi,Akiko Takatsu

DOI: https://doi.org/10.1007/s10337-022-04136-0

2022-02-26

Chromatographia

Abstract:Recently, we developed a sensitive and accurate quantification method for short-chain peptides using dual functional-group derivatization. Sensitive and accurate quantification was achieved in our study by separating the sensitivity-enhancement and isotope-labeling derivatization reactions. In this study, we applied the abovementioned method to quantify human insulin in serum using enzymatic digestion. The amino groups in human insulin were reductively alkylated with acetaldehyde or acetaldehyde-d4 to afford N-alkylated products with different masses. This process is simple, quick, produces high yields, and helps in the accurate comparative analysis of mass-differentiated human insulin. After mixing the N-alkylated products with different masses, the obtained mixtures were digested using Glu-C. The carboxyl groups were then derivatized with 1-(2-pyrimidinyl)piperazine to increase sensitivity and analyzed using liquid chromatography–tandem mass spectrometry. Excellent accuracy (97.2–107.5%) and precision (RSD, 2.2–10.6%) were achieved using this method. Furthermore, the quantification values obtained agreed with the quantification values obtained using isotope dilution mass spectrometry in a previous study.

chemistry, analytical,biochemical research methods
Utilizing ELISA-plate based immunopurification and liquid chromatography-tandem mass spectrometry for the urinary detection of short- and long acting human insulin analogues

Péter Judák,Peter Van Eenoo,Koen Deventer

DOI: https://doi.org/10.1016/j.jpba.2018.02.024

2018-05-10

Abstract:The measurement of human insulin and its synthetic analogues in biological matrices has become increasingly important not only in clinical fields but also in doping control. The use of insulin and its analogues have been included in the list of prohibited substances published by the World Anti-Doping Agency (WADA). This study describes a qualitative method for detection of insulin analogues (lispro, aspart, glulisine, glargine, degludec, detemir) in human urine. The sample preparation consists of a preconcentration step using ultrafiltration followed by an immunoaffinity extraction with an antibody precoated ELISA plate. The obtained extracts are analyzed by conventional high-performance liquid chromatography-electrospray tandem mass spectrometry (LC-ESI-MS/MS). The limits of detection range between 10 pg/ml and 150 pg/ml. The applicability of the method was proven by the analysis of real urine samples obtained from diabetic patients treated with synthetic insulin analogues.
Pesticide has asymmetric effects on two tadpole species across density gradient

Christopher A. Distel,M. Boone

DOI: https://doi.org/10.1002/etc.418

2011-03-01

Environmental Toxicology and Chemistry

Abstract:Northern leopard frogs (Rana pipiens) have been disappearing throughout their range. The causes for extirpations have been elusive, although habitat alteration appears to be a major factor. Pesticides have been implicated in declines in western amphibians, but no mechanism has been identified. We tested the hypothesis that leopard frog tadpoles would be eliminated from insecticide‐exposed ponds when they were less abundant than a competitor (American toads, Bufo americanus) by manipulating toad and leopard frog density (16, 50, or 150 of each species) with or without the insecticide carbaryl. Insecticide exposure did not interact with density on either species, indicating that contaminant effects were similar despite drastic differences in competition. The survival of both species decreased with increasing conspecific density, but not heterospecific density. Leopard frogs produced more metamorphs at intermediate densities, whereas toads produced more metamorphs at high density. Leopard frog mass at and time to metamorphosis responded negatively to density. Carbaryl did not affect leopard frog survival but positively affected mass at and time to metamorphosis. In contrast, toad survival was reduced after exposure, but mass at metamorphosis was greater. Pesticide‐induced survival reductions may not affect population size if reductions are slight (as in toads, whose fitness may be compensated by increased mass). Management strategies aimed at ameliorating the effects of carbaryl in systems with these two species may not need to consider density. Environ. Toxicol. Chem. 2011; 30:650–658. © 2011 SETAC
B-150 Chromatographic Separation and Quantitation of Human Insulin and Lispro Analog in Serum Using Liquid Chromatography High-Resolution Mass Spectrometry

M Campbell,K Moehnke,S K Grebe,A Maus

DOI: https://doi.org/10.1093/clinchem/hvae106.510

IF: 12.114

2024-10-27

Clinical Chemistry

Abstract:BackgroundFactitious hypoglycemia, a deliberate attempt to induce low blood glucose levels occurring secondary to the surreptitious administration of exogenous insulin, can be difficult to diagnose due to a variety of factors including the increased use of synthetic insulin analogs in clinical practice. Traditional insulin immunoassays demonstrate variable cross-reactivity with commonly prescribed insulin analogues and their metabolites, making it difficult to measure specific analogs. The development of liquid chromatography high resolution accurate mass (LC-HRAM)-mass spectrometry (MS) assays has largely circumvented the limitations of traditional immunoassays for detection and quantitation of insulin analogs. Analytical challenges remain, however, specifically in differentiating lispro, an isomeric human insulin analog formed by the transposition of proline and lysine near the C-terminal end of the B chain, from human insulin in patient samples due to the equivalent mass-to-charge ratios of their precursor ions.MethodsImmunoaffinity purification of insulin from calibrators and quality control material prepared by spiking insulin-depleted serum with pharmaceutical insulin preparations, as well as patient samples, was performed using tips coupled with anti-insulin monoclonal antibody. An automated liquid handler was programmed to perform aspiration and dispense cycles. Eluate from the purification protocol was submitted for analysis using a TLX-2 multiplex LC system paired with a Thermo Scientific Q Exactive Plus mass spectrometer. Various HPLC column chemistries were evaluated, a column passivation procedure was established, and column heater temperature was optimized to identify a combination of parameters yielding the best chromatographic separation of human insulin and lispro. Additionally, parallel reaction monitoring (PRM) targeted tandem mass spectrometry (MS/MS) analysis was utilized in combination with the full scan data to increase specificity through the monitoring of fragment ions produced from human insulin and each insulin analog.ResultsWe found that a 1000 Å Diphenyl, 2.7 μm, 2.1 x 100 mm analytical column in a column heater maintained at a temperature of 80°C allowed for human insulin and lispro to be differentiated as two chromatographically separated extracted ion chromatographic peaks (XICs) and quantified down to 2.5 mcIU/mL with near-baseline separation. Before use, the column required passivation with a high protein buffer (0.05% bovine serum albumin in 20% acetonitrile [ACN] + 0.2% acetic acid) followed by increasingly organic buffers (20% ACN + 0.2% acetic acid and 50% ACN + 0.2% acetic acid). MS/MS was used to confirm the presence of analogs detected.ConclusionsThe LC-HRAM-MS method described here, coupled with optimized column chemistry, column passivation, and proper column temperature control allows for chromatographic separation of human insulin and lispro. Incorporating a PRM scan into the mass spectrometry full scan method provides confirmation of the insulin detected in the XICs. The results obtained from preliminary studies suggest this method is appropriate for use to facilitate the clinical investigation of suspected factitious hypoglycemia with the ability to differentiate isomeric compounds, such as human insulin and lispro.

medical laboratory technology
Experimental gonococcal infection of the rabbit's eye, method of production.

C. P. Miller,M. J. Drell

DOI: https://doi.org/10.1093/INFDIS/77.3.193

1945-11-01

Abstract:
Derivatization-gas chromatographic analysis of cinoxacin in capsules as its pentafluorobenzyl derivative.

K. J. Wang,S. H. Chen,S. Lin,H. Wu

DOI: https://doi.org/10.1016/S0021-9673(00)91695-9

IF: 4.601

Journal of Chromatography A

Abstract:
Arbuscular mycorrhiza-induced shifts in foliar metabolism and photosynthesis mirror the developmental stage of the symbiosis and are only partly driven by improved phosphate uptake.

R. Schweiger,Markus C. Baier,C. Müller

DOI: https://doi.org/10.1094/MPMI-05-14-0126-R

IF: 3.4218

2014-11-11

Molecular Plant-Microbe Interactions

Abstract:In arbuscular mycorrhizal (AM) plants, the plant delivers photoassimilates to the arbuscular mycorrhizal fungus (AMF), whereas the mycosymbiont contributes, in addition to other beneficial effects, to phosphate (PO4(3-)) uptake from the soil. Thereby, the additional fungal carbon (C) sink strength in roots and improved plant PO4(3-) nutrition may influence aboveground traits. We investigated how the foliar metabolome of Plantago major is affected along with the development of root symbiosis, whether the photosynthetic performance is affected by AM, and whether these effects are mediated by improved PO4(3-) nutrition. Therefore, we studied PO4(3-)-limited and PO4(3-)-supplemented controls in comparison with mycorrhizal plants at 20, 30, and 62 days postinoculation with the AMF Rhizophagus irregularis. Foliar metabolome modifications were determined by the developmental stage of symbiosis, with changes becoming more pronounced over time. In a well-established stage of mature mutualism, about 60% of the metabolic changes and an increase in foliar CO2 assimilation were unrelated to the significantly increased foliar phosphorus (P) content. We propose a framework relating the time-dependent metabolic changes to the shifts in C costs and P benefits for the plant. Besides P-mediated effects, the strong fungal C sink activity may drive the changes in the leaf traits.
Optimization of a Coupling Process for Insulin Degludec According to a Quality by Design (qbd) Paradigm

Lei Nie,Mingming Hu,Xu Yan,Tingting Guo,Haibin Wang,Sheng Zhang,Haibin Qu

DOI: https://doi.org/10.1208/s12249-018-1032-1

IF: 3.3

2018-01-01

AAPS PharmSciTech

Abstract:This case study described a successful application of the quality by design (QbD) principles to a coupling process development of insulin degludec. Failure mode effects analysis (FMEA) risk analysis was first used to recognize critical process parameters (CPPs). Five CPPs, including coupling temperature (Temp), pH of desB30 solution (pH), reaction time (Time), desB30 concentration (Conc), and molar equivalent of ester per mole of desB30 insulin (MolE), were then investigated using a fractional factorial design. The curvature effect was found significant, indicating the requirement of second-order models. Afterwards, a central composite design was built with an augmented star and center points study. Regression models were developed for the CPPs to predict the purity and yield of predegludec using above experimental data. The R2 and adjusted R2 were higher than 96 and 93% for the two models respectively. The Q2 values were more than 80% indicating a good predictive ability of models. MolE was found to be the most significant factor affecting both yield and purity of predegludec. Temp, pH, and Conc were also significant for predegludec purity, while Time appeared to remarkably influence the yield model. The multi-dimensional design space and normal operating region (NOR) with a robust setpoint were determined using a probability-based Monte-Carlo simulation method. The verified experimental results showed that the design space was reliable and effective. This study enriches the understanding of acetylation process and is instructional to other complicated operations in biopharmaceutical engineering.
Formulation Optimization of Human Insulin Loaded Microspheres for Controlled Oral Delivery Using Response Surface Methodology

Gauravkuma Agrawal,Pravin Wakte,Santosh Shelke

DOI: https://doi.org/10.2174/1871530317666170503120129

Abstract:Objectives: The objectives of the present investigation were to prepare recombinant human insulin entrapped Eudragit-S100 microspheres containing protease inhibitors and to precisely analyze the outcome of different formulation variables on the microspheres properties using a response surface methodology to develop an optimized formulation with desirable features. Methods: A central composite design was employed to produce microspheres of therapeutic protein by w/o/w multiple emulsion solvent evaporation technique using Eudragit S-100 as coating material and polyvinyl alcohol as a stabilizer. The effect of formulation variables (independent variables) that is levels of Eudragit S-100 (X1), therapeutic protein (X2), volumes of inner aqueous phase (X3) and external aqueous phase (X4) on dependant variables, that are encapsulation efficiency (Y1), drug release at pH 1.2 after 2 h (Y2) and drug release at pH 7.4 after of 2 h (Y3) were evaluated. Results: The significant terms in the mathematical models were generated for each response parameter using multiple linear regression analysis and analysis of variance. All the formulation variables except the volume of external aqueous phase (X4) exerted a significant effect (P <0.05) on drug encapsulation efficiency (Y1) whereas first two variables, namely the levels of Eudragit S-100 (X1) and therapeutic protein (X2) materialized as the determining factors which significantly influenced drug release at pH 1.2 after 2 h (Y2) and drug release at pH 7.4 after of 2 h (Y3). The formulation was numerically optimized by framing the constraints on the dependent and independent variables using the desirability approach. The experimental values for Y1 and Y2 of optimized formulation were found to be 77.65% and 3.64%, respectively which were quite closer to results suggested by software. Conclusion: The results recorded indicate that the recombinant human insulin loaded Eudragit S-100 microspheres containing aprotinin have the benefits of higher loading efficiency, pH responsive and prolonged release characteristics, which may help to carry insulin to the optimum site of absorption.
Detection of recombinant insulins in human urine by liquid chromatography–electrospray ionization tandem mass spectrometry after immunoaffinity purification based on monolithic microcolumns

Monica Mazzarino,Marta Senofonte,Filippo Martinelli,Xavier de la Torre,Francesco Botrè

DOI: https://doi.org/10.1007/s00216-019-02203-4

2019-12-01

Analytical and Bioanalytical Chemistry

Abstract:This work describes an analytical procedure based on automated affinity purification followed by liquid chromatography–electrospray tandem mass spectrometry with a conventional triple quadrupole analyzer, in order to detect synthetic insulins (Apidra®, Humalog®, Levemir®, NovoRapid®, and Tresiba®) in human urine. Sample preparation included ultrafiltration followed by immunoaffinity purification on monolithic microcolumns. Chromatographic separation was performed by a C18 microbore column, while mass spectrometric identification of the analytes was achieved by a triple quadrupole mass spectrometer under positive ion electrospray ionization and acquisition mode in selected reaction monitoring. Identification of the synthetic insulins was performed by selecting at least two characteristic ion transitions for each analyte. The newly developed method was validated in terms of specificity, recovery, matrix effect, sensitivity, robustness, and repeatability of retention times and relative ion transition abundance. The specificity and the reproducibility of the relative retention times and the relative abundance of the characteristic ion transitions selected was confirmed to be fit for purposes of ensuring the unambiguous identification of all target analytes, also in the forensic field. The extraction yield was estimated at greater than 60% and the matrix effect smaller than 35%. The lower limits of detection were in the range of 0.02–0.05 ng/mL, proving the method to be sufficiently sensitive to detect the abuse of insulins in cases where they are used as performance-enhancing agents in sport. The applicability of the developed method was assessed by the analysis of urine samples obtained from diabetic subjects treated with Tresiba® and/or Humalog®, whose presence was confirmed in urine samples collected after the administration of therapeutic doses.A hybrid assay comprising MSIA-based immunoextraction combined with liquid chromatography–electrospray tandem mass spectrometry was developed and validated for the detection of recombinant insulins in human urine.

chemistry, analytical,biochemical research methods
Optimized LC-MS/MS method for quantifying insulin degludec and liraglutide in rat plasma and Tissues: Application in pharmacokinetics and biodistribution

Jeferson Ziebarth,Camila Diedrich,Christiane Schineider Machado,Rubiana Mara Mainardes

DOI: https://doi.org/10.1016/j.jchromb.2024.124015

2024-02-15

Abstract:We present an ultra-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous detection of insulin degludec (I-Deg) and liraglutide (LIRA) in rat plasma and tissues, characterized by its sensitivity and selectivity. Chromatographic separation was achieved using an Acquity UPLC BEH C18 column, leveraging a mobile phase of acetonitrile and water (both with 0.1 % formic acid) under gradient elution over a run time of 7.5 min. The mass spectrometer operated in positive electrospray ionization multiple reaction monitoring (MRM) mode, tracking transitions of m/z 1221.6 → 641.6 for I-Deg, m/z 938.7 → 1064.1 for LIRA, and m/z 1184.7 → 454.4 for the internal standard. Validation ranged from 5 to 100 ng/mL, exhibiting robust linearity (r2 > 0.99) and limits of detection (LOD) of 1.63-2.02 ng/mL for I-Deg and 0.96-1.62 ng/mL for LIRA. Limits of quantification (LOQ) were 2.38-4.76 ng/mL for I-Deg and 3.22-4.40 ng/mL for LIRA. Notably, no significant matrix effects were detected. Stability was confirmed under various conditions, and precision metrics (intraday RSD 1.68-8.05 % for I-Deg and 1.11-7.69 % for LIRA; interday RSD 1.39-8.61 % for I-Deg and 1.06-8.83 % for LIRA) alongside accuracy (90.5-114.9 % for I-Deg and 92.7-113.7 % for LIRA) were within acceptable ranges. The method was successfully applied to pharmacokinetic and biodistribution studies following simultaneous subcutaneous administration of LIRA and I-Deg in rats.
Elucidating the Degradation Pathways of Human Insulin in the Solid State

Andrew Fagan,Lorraine M Bateman,Joseph P O'Shea,Abina M Crean

DOI: https://doi.org/10.1007/s41664-024-00302-5

Abstract:While there have been significant advances in the development of peptide oral dosage forms in recent years, highlighted by the clinical and commercial success of approved peptides such as Rybelsus®, there remain several barriers in the way of broad range applicability of this approach to peptide delivery. One such barrier includes the poor physical and chemical stability inherent to their structures, which persists in the solid state although degradation typically occurs at different rates and via different pathways in comparison to the solution state. Using insulin as a model peptide, this work sought to contribute to the development of analytical techniques for investigating common insulin degradation pathways. Chemically denatured, deamidated and aggregated samples were prepared and used to benchmark circular dichroism spectroscopy, reverse phase HPLC and size exclusion chromatography methods for the investigation of unfolding, chemical modifications and covalent aggregation of the insulin molecule respectively. Solid state degraded samples were prepared by heating insulin powder at 60 °C and 75% relative humidity for 1, 3, 5 and 7 d, and the degradation profiles of the samples were evaluated and compared with those observed in solution. While no unfolding was observed to occur, significant deamidation and covalent aggregation were detected. Reductive disulfide bond cleavage using dithiothreitol allowed for separation of the insulin A- and B-chains, offering a facile yet novel means of assessing the mechanisms of deamidation and covalent aggregation occurring in the solid state. Supplementary information: The online version contains supplementary material available at 10.1007/s41664-024-00302-5.
Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin

Annie Moradian,Elisha Goonatilleke,Tai-Tu Lin,Maya Hatten-Beck,Michelle Emrick,Athena A Schepmoes,Thomas L Fillmore,Michael J MacCoss,Salvatore Sechi,Kimia Sobhani,Randie Little,Kuanysh Kabytaev,Jennifer E van Eyk,Wei-Jun Qian,Andrew N Hoofnagle

DOI: https://doi.org/10.1093/clinchem/hvae034

IF: 12.114

2024-03-29

Clinical Chemistry

Abstract:Abstract Background The enhanced precision and selectivity of liquid chromatography–tandem mass spectrometry (LC-MS/MS) makes it an attractive alternative to certain clinical immunoassays. Easily transferrable work flows could help facilitate harmonization and ensure high-quality patient care. We aimed to evaluate the interlaboratory comparability of antibody-free multiplexed insulin and C-peptide LC-MS/MS measurements. Methods The laboratories that comprise the Targeted Mass Spectrometry Assays for Diabetes and Obesity Research (TaMADOR) consortium verified the performance of a validated peptide-based assay (reproducibility, linearity, and lower limit of the measuring interval [LLMI]). An interlaboratory comparison study was then performed using shared calibrators, de-identified leftover laboratory samples, and reference materials. Results During verification, the measurements were precise (2.7% to 3.7%CV), linear (4 to 15 ng/mL for C-peptide and 2 to 14 ng/mL for insulin), and sensitive (LLMI of 0.04 to 0.10 ng/mL for C-peptide and 0.03 ng/mL for insulin). Median imprecision across the 3 laboratories was 13.4% (inter-quartile range [IQR] 11.6%) for C-peptide and 22.2% (IQR 20.9%) for insulin using individual measurements, and 10.8% (IQR 8.7%) and 15.3% (IQR 14.9%) for C-peptide and insulin, respectively, when replicate measurements were averaged. Method comparison with the University of Missouri reference method for C-peptide demonstrated a robust linear correlation with a slope of 1.044 and r2 = 0.99. CONCLUSIONS Our results suggest that combined LC-MS/MS measurements of C-peptide and insulin are robust and adaptable and that standardization with a reference measurement procedure could allow accurate and precise measurements across sites, which could be important to diabetes research and help patient care in the future.

medical laboratory technology
RSM optimization of HSA/IL1Ra in Pichia pastoris overexpression strain and study of its in vivo activity in reducing hyperglycemia of GK rats.

Wenhui Liu,Wenbin Zhao,Jun Lai,Qi Shen,Yingchun Xu,Liqiang Pan,Shuqing Chen

DOI: https://doi.org/10.1002/bab.1532

2017-01-01

Biotechnology and Applied Biochemistry

Abstract:Human serum albumin (HSA) and interleukin-1 receptor antagonist (IL1Ra) fusion protein is a potential long-acting drug in the treatment of type 2 diabetes. Previously, the expression level of HSA/IL1Ra in Pichia pastoris was successfully improved by increasing the gene copy number and coexpression with chaperone (protein disulfide isomerase) in our laboratory. However, the overexpression strain resulted in low production of high-cell-density fermentation. In this study, the culture medium was optimized in both flask and fermenter, and the optimum culture medium notably increased the productivity and stability of HSA/IL1Ra. To further improve the expression, response surface methodology was used to further optimize the culture condition through modeling three selected parameters (induction pH, induction temperature [T], and maximum methanol feed rate [V-m]). The maximum yield of HSA/IL1Ra reached 1.1 g/L (10-fold higher than original fermentation condition) under the optimized culture condition (pH 7.0, T = 29 degrees C and V-m = 4.82 mL/L/H) in a 5-L fermenter. In addition, the degradation position of HSA/IL1Ra during fermentation was determined to be K571, serving as a potential target for genetic modification strategies to reduce the degradation. Finally, the in vivo activity study showed that HSA/IL1Ra maintained the therapeutic effect of IL1Ra in type 2 diabetes model rats meanwhile reducing the frequency of administration. (C) 2016 International Union of Biochemistry and Molecular Biology, Inc.
Determination of zinc content in insulin products by inductively coupled plasma mass spectrometry

Yu. N. Shvetsova,A. A. Erina,E. A. Khorolskaya,E. S. Zhigilei,N. E. Kuz’mina

DOI: https://doi.org/10.30895/1991-2919-2023-13-3-394-402

2023-09-27

Abstract:Scientific relevance. Zinc content is a quality attribute of insulin products. The State Pharmacopoeia of the Russian Federation requires that it should be determined by flame atomic absorption spectrometry (FAAS). However, many pharmaceutical manufacturers currently prefer inductively coupled plasma mass spectrometry (ICP-MS), which is considered the most promising method for pharmaceutical and biomedical elemental analysis. Aim. The study aimed to develop and validate an ICP-MS-based analytical procedure for zinc content determination in insulin products. Materials and methods. The study focused on human insulin, insulin lispro, insulin aspart, and insulin glargine in the form of active substances, suspensions for subcutaneous injection, and solutions for injection from different manufacturers. Zinc content was determined on an Agilent 7900 ICP-MS; the analysis included 66Zn signal intensity registration. Results. The study compared the results of zinc content determination in test samples with either hydrochloric or nitric acid used as the solvent for sample preparation. The authors selected the experimental conditions to achieve relative standard deviations ( RSD s) of not more than 2.5% for the measurements. The ICP-MSbased analytical procedure was validated for its specificity, linearity, accuracy, and precision in the range of 0.4–1.6 mg/L. The authors compared the measurements of zinc content made using FAAS and ICP-MS. Conclusions. The ICP-MS-based analytical procedure for zinc content determination in insulin products meets the validation criteria. This analytical procedure, as developed and validated, may be used in the quality control of medicinal products in the Russian healthcare system and at the batch release stage of pharmaceutical manufacturing.
Pitfalls in Diagnosing Hypoglycemia Due to Exogenous Insulin: Validation and Utility of an Insulin Analog Assay

Aoife M Egan,Kornelia D Galior,Anthony D Maus,Erica Fatica,Vinaya Simha,Pankaj Shah,Ravinder J Singh,Adrian Vella

DOI: https://doi.org/10.1016/j.mayocp.2022.07.021

Abstract:Objective: To overcome the limitations of commercially available insulin immunoassays which have variable detection of analog insulin and can lead to clinically discordant results and misdiagnosis in the workup of factitious hypoglycemia. Patients and methods: We performed analytical validation of a liquid chromatography high resolution accurate mass (LC-HRAM) immunoassay to detect insulin analogs. We completed clinical assessment using a large cohort of human serum samples from 78 unique individuals, and subsequently used the assay in the evaluation of eight individuals with high diagnostic suspicion for factitious hypoglycemia. Results: The performance characteristics show that the LC-HRAM immunoassay can be applied to detect five commonly used synthetic insulin analogs (lispro, glulisine, aspart, glargine metabolite, and detemir) in human serum. Our clinical cases show that this assay could be used in the diagnosis of factitious hypoglycemia by identifying the analog insulin(s) in question. Conclusion: The LC-HRAM immunoassay reported here overcomes a gap in our diagnostic pathway for hypoglycemia. The results obtained from our studies suggest that this method is appropriate for use in clinical laboratories when factitious hypoglycemia is considered as a differential diagnosis.

[Causes of primary amenorrhea in children].

Simplified quantification of insulin, its synthetic analogs and C-peptide in human plasma by means of LC-HRMS

Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry

Quantification of Insulin Analogs by Liquid Chromatography-High-Resolution Mass Spectrometry

Hb Setif [alpha 94(G1)Asp-->Tyr] in Malta.

A Dual Functional-Group Derivatization Liquid Chromatography–Tandem Mass Spectrometry Method: Application for Quantification of Human Insulin

Utilizing ELISA-plate based immunopurification and liquid chromatography-tandem mass spectrometry for the urinary detection of short- and long acting human insulin analogues

Pesticide has asymmetric effects on two tadpole species across density gradient

B-150 Chromatographic Separation and Quantitation of Human Insulin and Lispro Analog in Serum Using Liquid Chromatography High-Resolution Mass Spectrometry

Experimental gonococcal infection of the rabbit's eye, method of production.

Derivatization-gas chromatographic analysis of cinoxacin in capsules as its pentafluorobenzyl derivative.

Arbuscular mycorrhiza-induced shifts in foliar metabolism and photosynthesis mirror the developmental stage of the symbiosis and are only partly driven by improved phosphate uptake.

Optimization of a Coupling Process for Insulin Degludec According to a Quality by Design (qbd) Paradigm

Formulation Optimization of Human Insulin Loaded Microspheres for Controlled Oral Delivery Using Response Surface Methodology

Detection of recombinant insulins in human urine by liquid chromatography–electrospray ionization tandem mass spectrometry after immunoaffinity purification based on monolithic microcolumns

Optimized LC-MS/MS method for quantifying insulin degludec and liraglutide in rat plasma and Tissues: Application in pharmacokinetics and biodistribution

Elucidating the Degradation Pathways of Human Insulin in the Solid State

Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin

RSM optimization of HSA/IL1Ra in Pichia pastoris overexpression strain and study of its in vivo activity in reducing hyperglycemia of GK rats.

Determination of zinc content in insulin products by inductively coupled plasma mass spectrometry

Pitfalls in Diagnosing Hypoglycemia Due to Exogenous Insulin: Validation and Utility of an Insulin Analog Assay